Does prior use of aspirin affect outcome in ischemic stroke?

American Journal of Medicine

Volumn 108, Issue 3, 2000, Pages 205-209

  Kalra, Lalit ^a   Perez, Inigo ^a   Smithard, David G ^b   Sulch, David ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b WILLIAM HARVEY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTIHYPERTENSIVE AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; INSULIN; ORAL ANTIDIABETIC AGENT; WARFARIN;

ADULT; AGED; ARTICLE; BRAIN ISCHEMIA; CAUSE OF DEATH; CEREBROVASCULAR DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; STROKE; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ASPIRIN; BRAIN ISCHEMIA; CASE-CONTROL STUDIES; CEREBROVASCULAR ACCIDENT; FEMALE; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; PROSPECTIVE STUDIES; RISK; SURVIVAL ANALYSIS;

EID: 0033981879     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(99)00431-3     Document Type: Article

References (16)

1. Antiplatelet Trialists Collaboration Group. Collaborative overview of randomized trials of antiplatelet therapy I. Prevention of death, myocardial infarction and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ. 1994;308:81-106.
2. International Stroke Trial Collaborative Group. The International Stroke Trial (IST). Lancet. 1997;349:1569-1581.
3. CAST (Chinese Acute Stroke Trial) Collaborative Group. CAST: randomized placebo-controlled trial of early aspirin use in 20,000 patients with acute ischemic stroke. Lancet. 1997;349:1641-1649.
4. Grotta JC, Lemak NA, Gary H, et al. Does platelet antiaggregant therapy lessen the severity of stroke? Neurology. 1985;35:632-636.
5. Joseph R, Han E, Grunfeld S, Welch KMA. Prior use of aspirin may reduce stroke severity. Ann Neurol. 1989;26:131.
6. De Keyser J, Herroelen L, De Kippel N. Early outcome in acute ischemic stroke is not influenced by the use of low dose aspirin. J Neurolog Sci. 1997;145:93-96.
7. Karepov V, Bornstein NM, Hass Y, Korczyn AD. Does daily aspirin diminish severity of first-ever stroke? Arch Neurol. 1997;54:1369-1371.
8. Sivenius J, Cunha L, Diener H-C, et al. Antiplatelet therapy does not affect subsequent stroke severity. J Neurolog Sci. 1997;150:S84-S85.
9. WHO Special Report. Stroke - 1989: recommendations on stroke prevention, diagnosis and therapy. Stroke. 1989;20:1407-1431.
10. Adams HP, Bendixen HB, Kappelle JL, et al. Classification of subtype of acute ischemic stroke: definitions for use in a multicentre clinical trial. Stroke. 1993;24:35-41.
11. Bamford J, Sandercock P, Dennis M, et al. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet. 1991;337:1521-1526.
12. Bamford JM, Warlow CP. Evolution and test ofthe lacunar hypothesis. Stroke. 1988;19:1074-1082.
13. Bornstein NH, Karepov VG, Aronovich BD, et al. Failure of aspirin treatment after stroke. Stroke. 1994;25:275-277.
14. Puranen J, Laasko M, Riekkinen P, Sivenius SJ. Risk factors and antiplatelet therapy in TIA and stroke patients. J Neurolog Sci. 1998; 154:200-204.
15. Rothrock JF, Lyden PD, Brody ML, et al. An analysis of ischemic stroke in an urban southern California population. The University of California, San Diego, Stroke Data Bank. Arch Intern Med. 1993; 153:619-624.
16. The National Institute of Neurological Disorders and Stroke rtPA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. NEJM. 1995;333:1581-1587.